Cite
HARVARD Citation
Cardile, S. et al. (n.d.). Lack of efficacy of infliximab (IFX) in the treatment of primary sclerosing cholangitis (PSC) in inflammatory bowel disease (IBD) in childhood. Digestive and liver disease. pp. e255-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cardile, S. et al. (n.d.). Lack of efficacy of infliximab (IFX) in the treatment of primary sclerosing cholangitis (PSC) in inflammatory bowel disease (IBD) in childhood. Digestive and liver disease. pp. e255-. [Online].